Literature DB >> 21910079

Sphingolipid metabolism and analysis in metabolic disease.

Sarah E Brice1, L Ashley Cowart.   

Abstract

Sphingolipids are an important class of structural and signaling molecules within the cell. As sphingolipids have been implicated in the development and pathogenesis of insulin resistance and the metabolic syndrome, it is important to understand their regulation and metabolism. Although these lipids are initially produced through a common pathway, there is no "generic" sphingolipid. Indeed, the biophysical and signaling properties of lipids may be manipulated by the subunit composition or isoform of their synthetic enzymes, via regulation of substrate integration. Functionally distinct pools of chemically-equivalent lipids may also be generated by de novo synthesis and recycling of existing complex sphingolipids. The highly integrated metabolism of the many bioactive sphingolipids means that manipulation of one enzyme or metabolite can result in a ripple effect, causing unforeseen changes in metabolite levels, enzyme activities, and cellular programmes. Fortunately, a suite of techniques, ranging from thin-layer chromatography to liquid chromatography-mass spectrometry approaches, allows investigators to undertake a functional characterization of all or part of the sphingolipidome in their systems of interest.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21910079     DOI: 10.1007/978-1-4614-0650-1_1

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  13 in total

Review 1.  Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology.

Authors:  Timothy Rohrbach; Michael Maceyka; Sarah Spiegel
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-06-15       Impact factor: 8.250

2.  Ceramide synthase 5 mediates lipid-induced autophagy and hypertrophy in cardiomyocytes.

Authors:  Sarah Brice Russo; Catalin F Baicu; An Van Laer; Tuoyu Geng; Harinath Kasiganesan; Michael R Zile; L Ashley Cowart
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

3.  Myriocin treatment of CF lung infection and inflammation: complex analyses for enigmatic lipids.

Authors:  Anna Caretti; Michele Vasso; Fabiola Tecla Bonezzi; Andrea Gallina; Marco Trinchera; Alice Rossi; Raffaella Adami; Josefina Casas; Monica Falleni; Delfina Tosi; Alessandra Bragonzi; Riccardo Ghidoni; Cecilia Gelfi; Paola Signorelli
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-24       Impact factor: 3.000

4.  Myristate-derived d16:0 sphingolipids constitute a cardiac sphingolipid pool with distinct synthetic routes and functional properties.

Authors:  Sarah Brice Russo; Rotem Tidhar; Anthony H Futerman; L Ashley Cowart
Journal:  J Biol Chem       Date:  2013-03-25       Impact factor: 5.157

5.  Molecular Characterization of the Lipid Genome-Wide Association Study Signal on Chromosome 18q11.2 Implicates HNF4A-Mediated Regulation of the TMEM241 Gene.

Authors:  Alejandra Rodríguez; Luis Gonzalez; Arthur Ko; Marcus Alvarez; Zong Miao; Yash Bhagat; Elina Nikkola; Ivette Cruz-Bautista; Olimpia Arellano-Campos; Linda L Muñoz-Hernández; Maria-Luisa Ordóñez-Sánchez; Rosario Rodriguez-Guillen; Karen L Mohlke; Markku Laakso; Teresa Tusie-Luna; Carlos A Aguilar-Salinas; Päivi Pajukanta
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-05-19       Impact factor: 8.311

Review 6.  Sphingolipids in obesity, type 2 diabetes, and metabolic disease.

Authors:  S B Russo; J S Ross; L A Cowart
Journal:  Handb Exp Pharmacol       Date:  2013

7.  Dietary Saturated Fat Promotes Development of Hepatic Inflammation Through Toll-Like Receptor 4 in Mice.

Authors:  Alton G Sutter; Arun P Palanisamy; Julie H Lench; Scott Esckilsen; Tuoyu Geng; David N B Lewin; Lauren A Cowart; Kenneth D Chavin
Journal:  J Cell Biochem       Date:  2015-12-08       Impact factor: 4.429

8.  Sphingolipid regulators of cellular dysfunction in Type 2 diabetes mellitus: a systems overview.

Authors:  Jessica S Ross; Sarah B Russo; Georgia C Chavis; Lauren A Cowart
Journal:  Clin Lipidol       Date:  2017-01-18

9.  Sphingolipid metabolic pathway: an overview of major roles played in human diseases.

Authors:  Raghavendra Pralhada Rao; Nanditha Vaidyanathan; Mathiyazhagan Rengasamy; Anup Mammen Oommen; Neeti Somaiya; M R Jagannath
Journal:  J Lipids       Date:  2013-08-04

10.  Risk of death in heart disease is associated with elevated urinary globotriaosylceramide.

Authors:  Raphael Schiffmann; Sabrina Forni; Caren Swift; Nastry Brignol; Xiaoyang Wu; David J Lockhart; Derek Blankenship; Xuan Wang; Paul A Grayburn; Matthew R G Taylor; Brian D Lowes; Maria Fuller; Elfrida R Benjamin; Lawrence Sweetman
Journal:  J Am Heart Assoc       Date:  2014-02-04       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.